REFERENCES
1. Norman AW. The history of the discovery of vitamin D and its daughter steroid hormone. Ann Nutr Metab 2012;61:199-206.
2. Calvo MS, Whiting SJ, Barton CN. Vitamin D intake: a global perspective of current status. J Nutr 2005;135:310-6.
3. Albarri EM, Sameer Alnuaimi A, Abdelghani D. Effectiveness of vitamin D2 compared with vitamin D3 replacement therapy in a primary healthcare setting: a retrospective cohort study. Qatar Med J 2022;2022:29.
4. Fu GK, Lin D, Zhang MY, et al. Cloning of human 25-hydroxyvitamin D-1 alpha-hydroxylase and mutations causing vitamin D-dependent rickets type 1. Mol Endocrinol 1997;11:1961-70.
5. Jones G, Strugnell SA, DeLuca HF. Current understanding of the molecular actions of vitamin D. Physiol Rev 1998;78:1193-231.
6. Holick MF. Vitamin D: The underappreciated d-lightful hormone that is important for skeletal and cellular health. Available from: https://journals.lww.com/co-endocrinology/abstract/2002/02000/vitamin_d__the_underappreciated_d_lightful_hormone.11.aspx [Last accessed on 12 Jan 2024].
7. Holick MF. Sunlight and vitamin D for bone health and prevention of autoimmune diseases, cancers, and cardiovascular disease. Am J Clin Nutr 2004;80:1678S-88S.
8. Holick MF. The vitamin D deficiency pandemic: approaches for diagnosis, treatment and prevention. Rev Endocr Metab Disord 2017;18:153-65.
9. Ricci JA, Chee E, Lorandeau AL, Berger J. Fatigue in the U.S. workforce: prevalence and implications for lost productive work time. J Occup Environ Med 2007;49:1-10.
10. Bhattoa HP, Konstantynowicz J, Laszcz N, Wojcik M, Pludowski P. Vitamin D: musculoskeletal health. Rev Endocr Metab Disord 2017;18:363-71.
11. Fleet JC. The role of vitamin D in the endocrinology controlling calcium homeostasis. Mol Cell Endocrinol 2017;453:36-45.
12. Khazai N, Judd SE, Tangpricha V. Calcium and vitamin D: skeletal and extraskeletal health. Curr Rheumatol Rep 2008;10:110-7.
13. Prietl B, Treiber G, Pieber TR, Amrein K. Vitamin D and immune function. Nutrients 2013;5:2502-21.
14. Gocek E, Studzinski GP. Vitamin D and differentiation in cancer. Crit Rev Clin Lab Sci 2009;46:190-209.
15. de la Guía-Galipienso F, Martínez-Ferran M, Vallecillo N, Lavie CJ, Sanchis-Gomar F, Pareja-Galeano H. Vitamin D and cardiovascular health. Clin Nutr 2021;40:2946-57.
16. Menon V, Kar SK, Suthar N, Nebhinani N. Vitamin D and depression: a critical appraisal of the evidence and future directions. Indian J Psychol Med 2020;42:11-21.
17. Wacker M, Holick MF. Sunlight and Vitamin D: a global perspective for health. Dermatoendocrinol 2013;5:51-108.
18. Kimlin MG, Olds WJ, Moore MR. Location and vitamin D synthesis: is the hypothesis validated by geophysical data? J Photochem Photobiol B 2007;86:234-9.
19. Jindal AK, Gupta A, Vinay K, Bishnoi A. Sun exposure in children: balancing the benefits and harms. Indian Dermatol Online J 2020;11:94-8.
20. Neale RE, Khan SR, Lucas RM, Waterhouse M, Whiteman DC, Olsen CM. The effect of sunscreen on vitamin D: a review. Br J Dermatol 2019;181:907-15.
21. Webb AR, Kazantzidis A, Kift RC, Farrar MD, Wilkinson J, Rhodes LE. Colour counts: sunlight and skin type as drivers of vitamin D deficiency at UK latItudes. Nutrients 2018;10:457.
22. Hartley M, Hoare S, Lithander FE, et al. Comparing the effects of sun exposure and vitamin D supplementation on vitamin D insufficiency, and immune and cardio-metabolic function: the sun exposure and vitamin D supplementation (SEDS) study. BMC Public Health 2015;15:115.
23. Autier P, Mullie P, Macacu A, et al. Effect of vitamin D supplementation on non-skeletal disorders: a systematic review of meta-analyses and randomised trials. Lancet Diabetes Endocrinol 2017;5:986-1004.
24. Alssageer MA, Alaasswad NM, Jebril AI, Ahmed HA, Almahdi RS. Knowledge, attitude and practice of Libyan medical students about vitamin D deficiency. Available from: https://www.ajol.info/index.php/mjpps/article/view/240629 [Last accessed on 15 Mar 2024].
25. Roche Diagnostics International Ltd. Elecsys ® Vitamin D Total Assay. Insert - elecsys vitamin D total III.09038086500.V2.en. Available from: https://www.scribd.com/document/690941582/Insert-Elecsys-Vitamin-D-total-III-09038086500-V2-en [Last accessed on 15 Mar 2024].
26. Holick MF, Binkley NC, Bischoff-Ferrari HA, et al. Endocrine Society. Evaluation, treatment, and prevention of vitamin D deficiency: an endocrine society clinical practice guideline. J Clin Endocrinol Metab 2011;96:1911-30.
27. Bahijri SM. Serum 25-hydroxy cholecalciferol in infants and preschool children in the Western region of Saudi Arabia Etiological factors. Saudi Med J 2001; 22:973-9.
28. Aljazzaf B, Alghazeer R, Swehli AI, et al. Association between vitamin D status and health status of adults in Western Libya. Processes 2023;11:930.
29. Ahmed A, Amr M, Almoner B, Salim M, Abudaber S. Evaluation of vitamin D status among adult population in Tripoli Region, Libya. Alq J Med App Sci 2023; 6:626-34.
30. Al-graiw M, Draid M, Zaidi A, Al-griw H. Serum Vitamin D levels and associated risk factors among libyan females living in Tripoli, Libya: a cross-sectional study. Libyan J Med Sci 2020;4:169.
31. Abumhdi AA, Azab EA, Albasha MO. Evaluation of Vitamin D Status among Populations in Alejelat, Libya. East African Scholars J Med Sci 2019 ; 2:666-73.
32. Omar M, Nouh F, Manal Y, et al. Culture, Sun Exposure and Vitamin D Deficiency in Benghazi Libya. Available from: http://classical.goforpromo.com/id/eprint/3002/ [Last accessed on 15 Mar 2024].
33. AlGhamdi KM, AlAklabi AS, AlQahtani AZ. Knowledge, attitudes and practices of the general public toward sun exposure and protection: A national survey in Saudi Arabia. Saudi Pharm J 2016;24:652-7.
34. Bougafa F, Tahir R. Evaluation of Vitamin D Status among Populations in Tobruk city, Libya. Available from: https://journal.utripoli.edu.ly/index.php/Alqalam/article/view/3 [Last accessed on 15 Mar 2024].
35. Alaasswad NM, Jebril AI, Ahmed HA, Almahdi RS, Alssageer MA. Vitamin D deficiency and anemia among pharmacy students. J Pharm Pharm Sci 2022;2:90-6.
36. Alalem AM, Younis M, Hawda SM, et al. The Frequency of Vitamin D and Calcium Deficiencies Among Women of Reproductive Age in Wadi Etba, Southern Region of Libya. Cureus 2022;14:e29832.
37. Ross A, Taylor C, Yaktine A, Del Valle HB. Dietary Reference Intakes for Calcium and Vitamin D. Washington (DC): National Academies Press (US); 2011.
38. Durazo-Arvizu RA, Tian L, Brooks SPJ, et al. The Vitamin D Standardization Program (VDSP) Manual for Retrospective Laboratory Standardization of Serum 25-Hydroxyvitamin D Data. J AOAC Int 2017;100:1234-43.
39. Zerwekh J. Blood biomarkers of vitamin D status. Available from: https://www.sciencedirect.com/science/article/pii/S0002916523235947 [Last accessed on 15 Mar 2024].
40. Ali AA. Estimation of evapotranspiration in Libya under the impact of plausible global climate change. Available from: https://www.geographiapolonica.pl/article/item/7843.html [Last accessed on 15 Mar 2024].
41. Fuleihan G. Vitamin D deficiency in the Middle East and its health consequences for children and adults. Available from: https://www.researchgate.net/profile/Suphia-Sherbeeni-2/publication/226836672_Vitamin_D_Deficiency_in_the_Middle_East_and_Its_Health_Consequences_for_Adults/links/551bf9990cf2909047b9889a/Vitamin-D-Deficiency-in-the-Middle-East-and-Its-Health-Consequences-for-Adults.pdf [Last accessed on 15 Mar 2024].
42. Algadid EM. Estimation of Serum Vitamin D Level among Patients Attending some Polyclinics in Sirte Libya. Available from: https://journal.su.edu.ly/index.php/susj/article/view/1378 [Last accessed on 15 Mar 2024.
43. Agila AR. Dietetic Cross Section Study on Vitamin D Deficiency in Tobruk, Libya. Available from: https://www.researchgate.net/profile/Amal-Agila/publication/354402457_Licensed_Under_Creative_Commons_Attribution_CC_BY_Dietetic_Cross_Section_Study_on_Vitamin_D_Deficiency_in_Tobruk_Libya/links/6137174438818c2eaf885a07/Licensed-Under-Creative-Commons-Attribution-CC-BY-Dietetic-Cross-Section-Study-on-Vitamin-D-Deficiency-in-Tobruk-Libya.pdf [Last accessed on 15 Mar 2024].
44. Bassil D, Rahme M, Hoteit M, Fuleihan Gel-H. Hypovitaminosis D in the Middle East and North Africa: prevalence, risk factors and impact on outcomes. Dermatoendocrinol 2013;5:274-98.
45. Kamen DL, Tangpricha V. Vitamin D and molecular actions on the immune system: modulation of innate and autoimmunity. J Mol Med 2010;88:441-50.
46. Sassi F, Tamone C, D'Amelio P. Vitamin D: nutrient, hormone, and immunomodulator. Nutrients 2018;10:1656.
47. Ao T, Kikuta J, Ishii M. The effects of vitamin D on immune system and inflammatory diseases. Biomolecules 2021;11:1624.
48. Mariani J, Antonietti L, Tajer C, et al. High-dose vitamin D versus placebo to prevent complications in COVID-19 patients: multicentre randomized controlled clinical trial. PLoS One 2022;17:e0267918.
49. Gordon PL, Sakkas GK, Doyle JW, Shubert T, Johansen KL. Relationship between vitamin D and muscle size and strength in patients on hemodialysis. J Ren Nutr 2007;17:397-407.
50. Janssen HC, Samson MM, Verhaar HJ. Vitamin D deficiency, muscle function, and falls in elderly people. Am J Clin Nutr 2002;75:611-5.
51. Bucurica S, Prodan I, Pavalean M, et al. Association of vitamin D deficiency and insufficiency with pathology in hospitalized patients. Diagnostics 2023;13:998.
53. Roy S, Sherman A, Monari-Sparks MJ, Schweiker O, Hunter K. Correction of low vitamin d improves fatigue: effect of correction of low vitamin d in fatigue study (EViDiF Study). N Am J Med Sci 2014;6:396-402.
54. Kerr DC, Zava DT, Piper WT, Saturn SR, Frei B, Gombart AF. Associations between vitamin D levels and depressive symptoms in healthy young adult women. Psychiatry Res 2015;227:46-51.
55. Knutsen KV, Brekke M, Gjelstad S, Lagerløv P. Vitamin D status in patients with musculoskeletal pain, fatigue and headache: a cross-sectional descriptive study in a multi-ethnic general practice in Norway. Scand J Prim Health Care 2010;28:166-71.
56. Arvold DS, Odean MJ, Dornfeld MP, et al. Correlation of symptoms with vitamin D deficiency and symptom response to cholecalciferol treatment: a randomized controlled trial. Endocr Pract 2009;15:203-12.
57. Witham MD, Adams F, McSwiggan S, et al. Effect of intermittent vitamin D3 on vascular function and symptoms in chronic fatigue syndrome--a randomised controlled trial. Nutr Metab Cardiovasc Dis 2015;25:287-94.
58. Zehnder D, Bland R, Williams MC, et al. Extrarenal expression of 25-hydroxyvitamin d(3)-1 alpha-hydroxylase. J Clin Endocrinol Metab 2001;86:888-94.
59. Hewison M, Zehnder D, Chakraverty R, Adams JS. Vitamin D and barrier function: a novel role for extra-renal 1 alpha-hydroxylase. Mol Cell Endocrinol 2004;215:31-8.
60. Townsend K, Evans KN, Campbell MJ, Colston KW, Adams JS, Hewison M. Biological actions of extra-renal 25-hydroxyvitamin D-1alpha-hydroxylase and implications for chemoprevention and treatment. J Steroid Biochem Mol Biol 2005;97:103-9.
61. Schwartz GG, Whitlatch LW, Chen TC, Lokeshwar BL, Holick MF. Human prostate cells synthesize 1,25-dihydroxyvitamin D3 from 25-hydroxyvitamin D3. Cancer Epidemiol Biomarkers Prev 1998;7:391-5.
62. Bareis P, Bises G, Bischof MG, Cross HS, Peterlik M. 25-hydroxy-vitamin d metabolism in human colon cancer cells during tumor progression. Biochem Biophys Res Commun 2001;285:1012-7.
63. Segersten U, Holm PK, Björklund P, et al. 25-Hydroxyvitamin D3 1alpha-hydroxylase expression in breast cancer and use of non-1alpha-hydroxylated vitamin D analogue. Breast Cancer Res 2005;7:R980-6.
64. Correa P, Segersten U, Hellman P, Akerstrom G, Westin G. Increased 25-hydroxyvitamin D3 1alpha-hydroxylase and reduced 25-hydroxyvitamin D3 24-hydroxylase expression in parathyroid tumors--new prospects for treatment of hyperparathyroidism with vitamin d. J Clin Endocrinol Metab 2002;87:5826-9.
65. Mensah GA, Wei GS, Sorlie PD, et al. Decline in cardiovascular mortality: possible causes and implications. Circ Res 2017;120:366-80.
66. Cosentino N, Campodonico J, Milazzo V, et al. Vitamin D and cardiovascular disease: current evidence and future perspectives. Nutrients 2021;13:3603.
67. Thompson B, Waterhouse M, English DR, et al. Vitamin D supplementation and major cardiovascular events: D-Health randomised controlled trial. BMJ 2023;381:e075230.
68. Holick MF. Vitamin D: important for prevention of osteoporosis, cardiovascular heart disease, type 1 diabetes, autoimmune diseases, and some cancers. South Med J 2005;98:1024-7.
69. Colley RC, Garriguet D, Janssen I, Craig CL, Clarke J, Trembla MS. Physical activity of Canadian adults: accelerometer results from the 2007 to 2009 Canadian health measures survey. Health Rep 2011;22:7-14.
70. Pirrotta F, Cavati G, Mingiano C, et al. Vitamin D deficiency and cardiovascular mortality: retrospective analysis "siena osteoporosis" cohort. Nutrients 2023;15:3303.
71. Mirhosseini N, Vatanparast H, Kimball SM. The association between Serum 25(OH)D status and blood pressure in participants of a community-based program taking vitamin D supplements. Nutrients 2017;9:1244.
72. Zhang R, Li B, Gao X, et al. Serum 25-hydroxyvitamin D and the risk of cardiovascular disease: dose-response meta-analysis of prospective studies. Am J Clin Nutr 2017;105:810-9.
73. 2019 Risk Factors Collaborators. Global burden of 87 risk factors in 204 countries and territories, 1990-2019: a systematic analysis for the global burden of disease study 2019. Lancet 2020;396:1223-49.
74. Bhatia LS, Curzen NP, Calder PC, Byrne CD. Non-alcoholic fatty liver disease: a new and important cardiovascular risk factor? Eur Heart J 2012;33:1190-200.
75. Riazi K, Azhari H, Charette JH, et al. The prevalence and incidence of NAFLD worldwide: a systematic review and meta-analysis. Lancet Gastroenterol Hepatol 2022;7:851-61.
76. Younossi ZM, Koenig AB, Abdelatif D, Fazel Y, Henry L, Wymer M. Global epidemiology of nonalcoholic fatty liver disease-Meta-analytic assessment of prevalence, incidence, and outcomes. Hepatology 2016;64:73-84.
77. Younossi Z, Henry L. Contribution of Alcoholic and Nonalcoholic Fatty Liver Disease to the Burden of Liver-Related Morbidity and Mortality. Gastroenterology 2016;150:1778-85.
78. Eliades M, Spyrou E. Vitamin D: a new player in non-alcoholic fatty liver disease? World J Gastroenterol 2015;21:1718-27.
79. Hao YP, Ma XJ, Luo YQ, et al. Serum vitamin D is associated with non-alcoholic fatty liver disease in Chinese males with normal weight and liver enzymes. Acta Pharmacol Sin 2014;35:1150-6.
80. Wang D, Lin H, Xia M, et al. Vitamin D Levels Are Inversely Associated with Liver Fat Content and Risk of Non-Alcoholic Fatty Liver Disease in a Chinese Middle-Aged and Elderly Population: The Shanghai Changfeng Study. PLoS One 2016;11:e0157515.
81. Kumar M, Parchani A, Kant R, Das A. Relationship between vitamin D deficiency and non-alcoholic fatty liver disease: a cross-sectional study from a tertiary care center in Northern India. Cureus 2023;15:e34921.
82. Wang N, Chen C, Zhao L, et al. Vitamin D and Nonalcoholic Fatty Liver Disease: Bi-directional Mendelian Randomization Analysis. EBioMedicine 2018;28:187-93.
83. Yuan S, Larsson SC. Inverse Association Between Serum 25-Hydroxyvitamin D and Nonalcoholic Fatty Liver Disease. Clin Gastroenterol Hepatol 2023;21:398-405.e4.
84. Kwok RM, Torres DM, Harrison SA. Vitamin D and nonalcoholic fatty liver disease (NAFLD): is it more than just an association? Hepatology 2013;58:1166-74.
85. Cimini FA, Barchetta I, Carotti S, et al. Relationship between adipose tissue dysfunction, vitamin D deficiency and the pathogenesis of non-alcoholic fatty liver disease. World J Gastroenterol 2017;23:3407-17.
86. Chatrath H, Vuppalanchi R, Chalasani N. Dyslipidemia in patients with nonalcoholic fatty liver disease. Semin Liver Dis 2012;32:22-9.
87. Garland CF, Garland FC. Do sunlight and vitamin D reduce the likelihood of colon cancer? Int J Epidemiol 1980;9:227-31.
88. Garland C, Shekelle RB, Barrett-Connor E, Criqui MH, Rossof AH, Paul O. Dietary vitamin D and calcium and risk of colorectal cancer: a 19-year prospective study in men. Lancet 1985;1:307-9.
89. Muñoz A, Grant WB. Vitamin D and Cancer: An Historical Overview of the Epidemiology and Mechanisms. Nutrients 2022;14:1448.
90. Gorham ED, Garland CF, Garland FC, et al. Optimal vitamin D status for colorectal cancer prevention: a quantitative meta analysis. Am J Prev Med 2007;32:210-6.
91. Fernandez-Garcia NI, Palmer HG, Garcia M, et al. 1alpha,25-Dihydroxyvitamin D3 regulates the expression of Id1 and Id2 genes and the angiogenic phenotype of human colon carcinoma cells. Oncogene 2005;24:6533-44.
92. Hanel A, Neme A, Malinen M, et al. Common and personal target genes of the micronutrient vitamin D in primary immune cells from human peripheral blood. Sci Rep 2020;10:21051.
93. Ferrer-Mayorga G, Larriba MJ, Crespo P, Muñoz A. Mechanisms of action of vitamin D in colon cancer. J Steroid Biochem Mol Biol 2019;185:1-6.
94. Sung V, Feldman D. 1,25-Dihydroxyvitamin D3 decreases human prostate cancer cell adhesion and migration. Mol Cell Endocrinol 2000;164:133-43.
95. Tokar EJ, Webber MM. Cholecalciferol (vitamin D3) inhibits growth and invasion by up-regulating nuclear receptors and 25-hydroxylase (CYP27A1) in human prostate cancer cells. Clin Exp Metastasis 2005;22:275-84.
96. Kutuzova GD, DeLuca HF. 1,25-Dihydroxyvitamin D3 regulates genes responsible for detoxification in intestine. Toxicol Appl Pharmacol 2007;218:37-44.
97. Lindh JD, Björkhem-Bergman L, Eliasson E. Vitamin D and drug-metabolising enzymes. Photochem Photobiol Sci 2012;11:1797-801.
98. Song Y, Wang L, Pittas AG, et al. Blood 25-hydroxy vitamin D levels and incident type 2 diabetes: a meta-analysis of prospective studies. Diabetes Care 2013;36:1422-8.
99. Mitri J, Dawson-Hughes B, Hu FB, Pittas AG. Effects of vitamin D and calcium supplementation on pancreatic β cell function, insulin sensitivity, and glycemia in adults at high risk of diabetes: the Calcium and Vitamin D for Diabetes Mellitus (CaDDM) randomized controlled trial. Am J Clin Nutr 2011;94:486-94.
100. Dawson-Hughes B, Staten MA, Knowler WC, et al. D2d Research Group. Intratrial Exposure to Vitamin D and New-Onset Diabetes Among Adults With Prediabetes: A Secondary Analysis From the Vitamin D and Type 2 Diabetes (D2d) Study. Diabetes Care 2020;43:2916-22.
101. Pittas AG, Dawson-Hughes B, Sheehan P, et al. D2d Research Group. Vitamin D Supplementation and Prevention of Type 2 Diabetes. N Engl J Med 2019;381:520-30.
102. Jorde R, Sollid ST, Svartberg J, et al. Vitamin D 20,000 IU per Week for Five Years Does Not Prevent Progression From Prediabetes to Diabetes. J Clin Endocrinol Metab 2016;101:1647-55.
103. Kawahara T, Suzuki G, Mizuno S, et al. Effect of active vitamin D treatment on development of type 2 diabetes: DPVD randomised controlled trial in Japanese population. BMJ 2022;377:e066222.
104. Tobias DK, Luttmann-Gibson H, Mora S, et al. Association of Body Weight With Response to Vitamin D Supplementation and Metabolism. JAMA Netw Open 2023;6:e2250681.
105. Manson JE. Vitamin D and Type 2 Diabetes: New Insights. Available from: https://www.medscape.com/viewarticle/988153?form=fpf [Last accessed on 15 Mar 2024].
106. Campi I, Gennari L, Merlotti D, et al. Vitamin D and COVID-19 severity and related mortality: a prospective study in Italy. BMC Infect Dis 2021;21:566.
107. Petrelli F, Luciani A, Perego G, Dognini G, Colombelli PL, Ghidini A. Therapeutic and prognostic role of vitamin D for COVID-19 infection: a systematic review and meta-analysis of 43 observational studies. J Steroid Biochem Mol Biol 2021;211:105883.
108. Chiu SK, Tsai KW, Wu CC, et al. Putative role of vitamin D for COVID-19 vaccination. Int J Mol Sci 2021;22:8988.
109. Brito DTM, Ribeiro LHC, Daltro CHDC, Silva RB. The possible benefits of vitamin D in COVID-19. Nutrition 2021;91-2:111356.
110. Varikasuvu SR, Thangappazham B, Vykunta A, et al. COVID-19 and vitamin D (Co-VIVID study): a systematic review and meta-analysis of randomized controlled trials. Expert Rev Anti Infect Ther 2022;20:907-13.
111. Mulligan ML, Felton SK, Riek AE, Bernal-Mizrachi C. Implications of vitamin D deficiency in pregnancy and lactation. Am J Obstet Gynecol 2010;202:429.e1-9.
112. Clifton-Bligh RJ, McElduff P, McElduff A. Maternal vitamin D deficiency, ethnicity and gestational diabetes. Diabet Med 2008;25:678-84.
113. Karras SN, Anagnostis P, Bili E, et al. Maternal vitamin D status in pregnancy and offspring bone development: the unmet needs of vitamin D era. Osteoporos Int 2014;25:795-805.
114. Rostami M, Tehrani FR, Simbar M, et al. Effectiveness of prenatal vitamin D deficiency screening and treatment program: a stratified randomized field trial. J Clin Endocrinol Metab 2018;103:2936-48.
115. Karras S, Paschou SA, Kandaraki E, et al. Hypovitaminosis D in pregnancy in the Mediterranean region: a systematic review. Eur J Clin Nutr 2016;70:979-86.
116. Pérez-López FR, Fernández-Alonso AM, Ferrando-Marco P, et al. First trimester serum 25-hydroxyvitamin D status and factors related to lower levels in gravids living in the Spanish mediterranean coast. Reprod Sci 2011;18:730-6.
117. Halicioglu O, Aksit S, Koc F, et al. Vitamin D deficiency in pregnant women and their neonates in spring time in western Turkey. Paediatr Perinat Epidemiol 2012;26:53-60.
118. Eltaweel HO, Garcia MDN, Embaea H, Albori F, Algherrabi A. Prevalence of vitamin D insufficiency and its associated risk factors among pregnant women in selected clinics in Misurata, Libya. Available from: https://journals.misuratau.edu.ly/mmsj/upload/file/R-1541-8Prevalence%20of%20Vitamin%20D%20Insufficiency.pdf [Last accessed on 15 Mar 2024].
119. Esadawi A, Alrutbi M, Shkurfu AO. Prevalence of vitamin D during second trimester of pregnancy women in Alkhoms City, Libya. Available from: https://www.majltaloulum.org/single-post/prevalence-of-vitamin-d-during-second-trimester-of-pregnancy-women-in-alkhoms-city-libya [Last accessed on 20 Mar 2024].
120. Álvarez-mercado AI, Mesa MD, Gil Á. Vitamin D: role in chronic and acute diseases. Encyclopedia of Human Nutrition. Elsevier; 2023. pp. 535-44.
121. Manson JE. Vitamin D: recent findings and implications for clinical practice medscape. Available from: https://www.medscape.com/viewarticle/982190?form=fpf [Last accessed on 15 Mar 2024].
122. Hahn J, Cook NR, Alexander EK, et al. Vitamin D and marine omega 3 fatty acid supplementation and incident autoimmune disease: VITAL randomized controlled trial. BMJ 2022;376:e066452.
123. Chandler PD, Chen WY, Ajala ON, et al. VITAL Research Group. Effect of vitamin D3 supplements on development of advanced cancer: a secondary analysis of the VITAL randomized clinical trial. JAMA Netw Open 2020;3:e2025850.
124. Nimitphong H, Holick MF. Vitamin D status and sun exposure in southeast Asia. Dermatoendocrinol 2013;5:34-7.
125. Perampalam S, Ganda K, Chow KA, et al. Vitamin D status and its predictive factors in pregnancy in 2 Australian populations. Aust N Z J Obstet Gynaecol 2011;51:353-9.
126. Libon F, Cavalier E, Nikkels AF. Skin color is relevant to vitamin D synthesis. Dermatology 2013;227:250-4.
127. Levy MA, McKinnon T, Barker T, et al. Predictors of vitamin D status in subjects that consume a vitamin D supplement. Eur J Clin Nutr 2015;69:84-9.
128. Holmes VA, Barnes MS, Alexander HD, McFaul P, Wallace JM. Vitamin D deficiency and insufficiency in pregnant women: a longitudinal study. Br J Nutr 2009;102:876-81.
129. Pfeifer M, Begerow B, Minne HW, Nachtigall D, Hansen C. Effects of a short-term vitamin D3 and calcium supplementation on blood pressure and parathyroid hormone levels in elderly women. J Clin Endocrinol Metab 2001;86:1633-7.
131. Holick MF, Garabedian M. Vitamin D: photobiology, metabolism, mechanisms of action, and clinical applications. Available from: https://www.researchgate.net/publication/313009630_Vitamin_D_photobiology_metabolism_mechanism_of_action_and_clinical_applications [Last accessed on 15 Mar 2024].
132. Shoenfeld N, Amital H, Shoenfeld Y. The effect of melanism and vitamin D synthesis on the incidence of autoimmune disease. Nat Clin Pract Rheumatol 2009;5:99-105.
133. Kaddam IM, Al-Shaikh AM, Abaalkhail BA, et al. Prevalence of vitamin D deficiency and its associated factors in three regions of Saudi Arabia. Saudi Med J 2017;38:381-90.
